Chew E Y
National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
Curr Opin Ophthalmol. 1995 Jun;6(3):19-24. doi: 10.1097/00055735-199506000-00004.
Age-related macular degeneration is one of the leading causes of visual loss among people aged 65 years or older. The causes and factors associated with the progression of age-related macular degeneration are unknown presently. Basic research and epidemiologic data support the hypotheses that higher levels of antioxidant vitamins and minerals may protect the eye from the development of age-related macular degeneration. For this reason and also because of the lack of effective treatment for most cases of age-related macular degeneration, nutritional supplements with antioxidants have emerged as possible therapy for age-related macular degeneration. Nutritional supplements are not proven therapy for age-related macular degeneration. The potential beneficial effects and adverse side effects of the nutritional supplements have not yet been fully evaluated in carefully conducted clinical trials. Several randomized placebo-controlled clinical trials are presently underway. Results of these studies will provide important data to clarify the potential beneficial and adverse effects of such treatment. Until these results are available, it would be premature to make recommendations in favor of vitamin or mineral supplements.
年龄相关性黄斑变性是65岁及以上人群视力丧失的主要原因之一。目前,与年龄相关性黄斑变性进展相关的病因和因素尚不清楚。基础研究和流行病学数据支持这样的假说:较高水平的抗氧化维生素和矿物质可能保护眼睛免受年龄相关性黄斑变性的侵害。出于这个原因,也由于大多数年龄相关性黄斑变性病例缺乏有效的治疗方法,含有抗氧化剂的营养补充剂已成为年龄相关性黄斑变性的一种可能治疗方法。营养补充剂尚未被证实可用于治疗年龄相关性黄斑变性。营养补充剂的潜在益处和副作用尚未在精心开展的临床试验中得到充分评估。目前正在进行几项随机安慰剂对照临床试验。这些研究的结果将提供重要数据,以阐明这种治疗的潜在益处和不良影响。在获得这些结果之前,就推荐使用维生素或矿物质补充剂还为时过早。